YFY Biotech Management Company
About Us
Company Profile
Management Team
Capital Funds
Portfolio
News
Contact Us
繁體
English
News
SEARCH
Year
2024
2023
2022
2021
2020
2019
2018
2017
May 30, 2017
TaiGen Biotechnology Announces Submission of New Drug Application for Taigexyn Intravenous Formulation to the China Food
READ MORE
May 19, 2017
TLC Submits Marketing Authorization Application in Europe for TLC177
READ MORE
May 15, 2017
Mycenax announced an exclusive worldwide license for the development of immune checkpoint antibody
READ MORE
May 4, 2017
TaiMed Submits Biologics License Application for HIV Monoclonal Antibody and Long-Acting Investigational Antiretroviral
READ MORE
May 2, 2017
Medeon Biodesign Announces Approval to Begin CE Clinical Study for the XProTM Large Bore Vascular Closure System
READ MORE
Apr 26, 2017
TLC178 Designated by US FDA as Drug for Rare Pediatric Disease in the Treatment of Rhabdomyosarcoma
READ MORE
Mar 28, 2017
MEDEON BIODESIGN ANNOUNCES INVESTING IN PANTHER ORTHOPEDICS FOR ORTHOPEDIC EXTREMITY APPLICATIONS
READ MORE
Mar 27, 2017
License agreement with ADARC for Bispecific Antibodies technology
READ MORE
prev
1
2
3
4
5
next
YFY Biotech Management Company